Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inner ear function in children with Fabry disease.

A Keilmann1

  • 1Department for Communication Disorders, University of Mainz, Mainz, Germany. keilmann@kommunikation.klinik.uni-mainz.de

Acta Paediatrica (Oslo, Norway : 1992). Supplement
|March 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The new Mainz Audiometric Test for Children aged 3-7 years (MATCH) in noise : Design, normalization, and validation].

HNO·2026
Same author

The new Mainz speech test for children 3-7 years old (MATCH) : Design, standardization, and validation.

HNO·2020
Same author

[The new Mainz speech test for children aged 3-7 years (MATCH) : Design, standardization, and validation. German version].

HNO·2019
Same author

[Cogan-I-syndrome.A rare differential diagnosis in progressive sensorineural hearing loss].

HNO·2017
Same author

Alterations of mucosa of the larynx and hypopharynx in patients with mucopolysaccharidoses.

The Journal of laryngology and otology·2015
Same author

[Diagnostic Accuracy of the LiSe-DaZ for Children with Specific Language Impairment].

Laryngo- rhino- otologie·2015

Hearing loss is uncommon in young Fabry disease patients, but tinnitus may be an early indicator. This study assessed auditory function in pediatric patients undergoing enzyme replacement therapy (ERT).

Area of Science:

  • Otolaryngology
  • Genetics
  • Pediatrics

Background:

  • Fabry disease is a rare genetic disorder with uncertain hearing loss prevalence.
  • Auditory dysfunction is a potential, yet understudied, manifestation in pediatric Fabry disease.

Purpose of the Study:

  • To investigate the prevalence and characteristics of hearing loss in young patients with Fabry disease.
  • To evaluate auditory function in children and adolescents receiving enzyme replacement therapy (ERT).

Main Methods:

  • Comprehensive audiological assessments including pure-tone audiometry, speech audiometry, and tympanometry were performed.
  • Evaluations included clinical ear, nose, and throat examinations.
  • The study included six pediatric patients (four girls, two boys) aged 7-17 years undergoing ERT.

Related Experiment Videos

Main Results:

  • No patients exhibited hearing loss or reported hearing disorders.
  • Tinnitus was reported by three female patients, though not as a significant issue.
  • One male patient reported new-onset tinnitus during the 6-month ERT period.

Conclusions:

  • Hearing impairment in Fabry disease appears to manifest primarily in adulthood.
  • Tinnitus may serve as an earlier symptom of Fabry disease than previously recognized.
  • Further research is needed to confirm tinnitus as an early auditory biomarker in pediatric Fabry disease.